United States Antimony Corporation

As of June 30, 2026, United States Antimony Corporation carries a market capitalization of 22.58B, placing it among publicly traded companies globally. Its enterprise value stands at 21.78B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

United States Antimony Corporation's next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, United States Antimony Corporation has 149.47M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 32.72, and the price-to-book ratio stands at 7.14.

These figures are as of June 30, 2026. The EV/Sales ratio of 34.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 21.78B versus a market cap of 22.58B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, United States Antimony Corporation maintains a current ratio of 11.54, meaning it holds 11.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, United States Antimony Corporation posted a negative return on equity (ROE) of -14.88, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -13.65, reflecting losses generated across the asset base. The company generates approximately 6.98M in revenue per employee across its workforce of 91.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.12 indicates how many times United States Antimony Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures are as of the close on October 14, 2026.

Over the twelve months ended June 30, 2026, United States Antimony Corporation generated 636.70M in revenue and converted that into -283.95M in net income, yielding earnings per share of -2.04. EBITDA reached -380.92M, while operating income came in at -415.03M.

As of June 30, 2026, United States Antimony Corporation holds 805.45M in cash and equivalents against 6.36M in total debt, resulting in a net debt position of -718.08M. Total book value stands at 3.16B, with working capital of 1.22B providing operational flexibility.

United States Antimony Corporation produced -490.15M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -755.26M in capital expenditures, free cash flow totaled -1.25B - equivalent to -9.03 per share.

Over the twelve months ended June 30, 2026, United States Antimony Corporation posted a gross margin of 17.44, reflecting its pricing power and cost economics. The operating margin of -65.18 and net profit margin of -44.60 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 0.05 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -5.92: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -11.27, meaning United States Antimony Corporation raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, United States Antimony Corporation has an Altman Z-Score of 80.62, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.